Karen Moorhouse, CEO of the International Tennis Integrity Agency (ITIA), dives deep into the intricacies of tennis drug testing and the significant Jannik Sinner case. She sheds light on WADA's involvement and the complexities surrounding doping violations. Moorhouse discusses the importance of consistency in handling such matters and the challenges players face when proving their innocence. The conversation also touches on the growing issue of positive tests among top athletes and the critical need for improved education on anti-doping regulations.